Table 3. Association between the genes and clinical features.
| Variables | miR-383-5p expression | Total samples | Pearson r | P-value | |
|---|---|---|---|---|---|
| Low (n, %) | High (n, %) | ||||
| Age | |||||
| <60 | 11 (17.1) | 12 (13.4) | 23 | −0.037 | 0.783 |
| ≥60 | 16 (28.0) | 15 (41.5) | 31 | ||
| Gender | |||||
| Male | 17 (32.9) | 13 (28.1) | 30 | 0.149 | 0.273 |
| Female | 10 (25.6) | 14 (13.4) | 24 | ||
| Tumour size | |||||
| ≤5 cm | 5 (9.8) | 14 (15.9) | 19 | −0.349 | 0.010* |
| >5 cm | 22 (48.8) | 13 (25.6) | 35 | ||
| Lymph node metastasis | |||||
| Negative | 12 (13.4) | 18 (19.5) | 30 | −0.224 | 0.100 |
| Positive | 15 (45.1) | 9 (22.0) | 24 | ||
| TNM stage | |||||
| I + II | 13 (28.0) | 20 (15.9) | 33 | −0.266 | 0.051 |
| III + IV | 14 (30.5) | 7 (25.6) | 21 | ||
| Differentiation grade | |||||
| Well and moderate | 6 (17.1) | 16 (18.3) | 22 | −0.377 | 0.006* |
| Poor | 21 (41.5) | 11 (23.2) | 32 | ||
Note:
*
P < 0.05, statistically significant.